Adenokarzinome des ösophagogastralen Übergangs

Die Adenokarzinome des ösophagogastralen Übergangs (AEG-Tumoren) werden anhand der Tumorlokalisation in Bezug zur Z-Linie als anatomische Landmarke unterteilt. Verschiedene Klassifikationssysteme haben sich hier etabliert (Siewert, Nishi, TNM/UICC). Die genaue Kenntnis über die Tumorlokalisation ist von höchster klinischer Relevanz, da sie wesentlichen Einfluss auf die Operationsstrategie hat. Dieser Beitrag stellt die wesentlichen Aspekte dieser divergenten Tumorgruppe vor.

• Literatur

• 1 Hayashi T, Yoshikawa T. Optimal surgery for esophagogastric junctional cancer. Langenbecks Arch Surg 2022; 407: 1399-1407
• 2 Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998; 85: 1457-1459
• 3 Nishi M, Kajisa T, Akune T. et al. Cardia cancer: proposal of cancer in the esophagogastric junction. Geka Shinryo (Surgical Diagnosis Treatment) 1973; 15: 1328-1338
• 4 Kroese TE, van Rossum PSN, Nilsson M. et al. Study protocol for the OligoMetastatic Esophagogastric Cancer (OMEC) project: a multidisciplinary European consensus project on the definition and treatment for oligometastatic esophagogastric cancer. Eur J Surg Oncol 2023; 49: 21-28
• 5 Kroese TE, van Laarhoven HWM, Nilsson M. et al. Definition of oligometastatic esophagogastric cancer and impact of local oligometastasis-directed treatment: a systematic review and meta-analysis. Eur J Cancer 2022; 166: 254-269
• 6 Porschen R, Fischbach W, Gockel I. et al. S3-Leitlinie – Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus. Z Gastroenterol 2019; 57: 336-418
• 7 Porschen R, Fischbach W, Gockel I. et al. Updated German guideline on diagnosis and treatment of squamous cell carcinoma and adenocarcinoma of the esophagus. United Eur Gastroenterol J 2024; 12: 399-411
• 8 Lordick F, Carneiro F, Cascinu S. et al. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol 2022; 33: 1005-1020
• 9 Rice TW, Patil DT, Blackstone EH. AJCC/UICC staging of cancers of the esophagus and esophagogastric junction (8th edn): application to clinical practice. Ann Cardiothorac Surg 2017; 6: 119-130
• 10 Bayley EM, Ivy ML, Shewale JB. et al. High-risk features of esophageal adenocarcinoma following neoadjuvant chemoradiation: patients for whom surgery should not be delayed. Ann Surg 2023; 277: 721-726
• 11 Hoeppner J, Plum PS, Buhr H. et al. Chirurgische Therapie des Ösophaguskarzinoms – Qualitätsindikatoren für Diagnostik und Therapie. Chirurg 2021; 92: 350-360
• 12 Boys JA, Worrell SG, Chandrasoma P. et al. Can the risk of lymph node metastases be gauged in endoscopically resected submucosal esophageal adenocarcinomas? A multi-center study. J Gastrointest Surg 2016; 20: 6-12
• 13 Al-Haddad MA, Elhanafi SE, Forbes N. et al. American Society for Gastrointestinal Endoscopy guideline on endoscopic submucosal dissection for the management of early esophageal and gastric cancers: methodology and review of evidence. Gastrointest Endosc 2023; 98: 285-305.e38
• 14 van Hagen P, Hulshof MCCM, van Lanschot JJB. et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012; 366: 2074-2084
• 15 Al-batran SE, Hartmann JT, Hofheinz R. et al. Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie. Ann Oncol 2008; 19: 1882-1887
• 16 Langer R, Becker K, Zlobec I. et al. A multifactorial histopathologic score for the prediction of prognosis of resected esophageal adenocarcinomas after neoadjuvant chemotherapy. Ann Surg Oncol 2014; 21: 915-921
• 17 Realis Luc M, Bonomi AM, Carbone F. et al. Roux-en-Y with or without jejunal J-pouch reconstruction after total gastrectomy for gastric cancer: systematic review and meta-analysis of long-term functional outcomes. J Gastrointest Surg 2024; 28: 291-300
• 18 Li B, Wang Y, Li B. et al. Short-term outcomes and long-term quality of life of reconstruction methods after proximal gastrectomy: a systematic review and meta-analysis. BMC Cancer 2024; 24: 56
• 19 Yamashita H, Seto Y, Sano T. et al. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma. Gastric Cancer 2017; 20: 69-83
• 20 Van der Sluis PC, van der Horst S, May AM. et al. Robot-assisted Minimally Invasive Thoracolaparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy for Resectable Esophageal Cancer: A Randomized Controlled Trial. Ann Surg 2019; 269: 621-630
• 21 Perry R, Barbosa JP, Perry I. et al. Short-term outcomes of robot-assisted versus conventional minimally invasive esophagectomy for esophageal cancer: a systematic review and meta-analysis of 18,187 patients. J Robot Surg 2024; 18: 125
• 22 Angeramo CA, Bras Harriott C, Casas MA. et al. Minimally invasive Ivor Lewis esophagectomy: Robot-assisted versus laparoscopic-thoracoscopic technique. Systematic review and meta-analysis. Surgery 2021; 170: 1692-1701
• 23 Jeon YH, Yun JK, Jeong YH. et al. Surgical outcomes of 500 robot-assisted minimally invasive esophagectomies for esophageal carcinoma. J Thorac Dis 2023; 15: 4745-4756
• 24 Knitter S, Maurer MM, Winter A. et al. Robotic-Assisted Ivor Lewis Esophagectomy Is Safe and Cost Equivalent Compared to Minimally Invasive Esophagectomy in a Tertiary Referral Center. Cancers (Basel) 2023; 16: 112
• 25 Van der Veen A, Brenkman HJF, Seesing MFJ. et al. Laparoscopic Versus Open Gastrectomy for Gastric Cancer (LOGICA): A Multicenter Randomized Clinical Trial. J Clin Oncol 2021; 39: 978-989
• 26 Li ZY, Wei B, Zhou YB. et al. Long-term oncological outcomes of robotic versus laparoscopic gastrectomy for gastric cancer: multicentre cohort study. Br J Surg 2024; 111: znad435
• 27 Ojima T, Nakamura M, Hayata K. et al. Short-term Outcomes of Robotic Gastrectomy vs Laparoscopic Gastrectomy for Patients With Gastric Cancer: A Randomized Clinical Trial. JAMA Surg 2021; 156: 954-963
• 28 van der Werf LR, Busweiler LAD, van Sandick JW. et al. Reporting national outcomes after esophagectomy and gastrectomy according to the Esophageal Complications Consensus Group (ECCG). Ann Surg 2019; 271: 1095-1101
• 29 Low DE, Alderson D, Cecconello I. et al. International consensus on standardization of data collection for complications associated with esophagectomy: Esophagectomy Complications Consensus Group (ECCG). Ann Surg 2015; 262: 286-294
• 30 Oesophago-Gastric Anastomosis Study Group, West Midlands Research Collaborative. Rates of anastomotic complications and their management following esophagectomy: results of the Oesophago-Gastric Anastomosis Audit (OGAA). Ann Surg on behalf of the 2022; 275: e382-e391
• 31 Plum PS, Herbold T, Berlth F. et al. Outcome of self-expanding metal stents in the treatment of anastomotic leaks after Ivor Lewis esophagectomy. World J Surg 2019; 43: 862-869
• 32 Berlth F, Bludau M, Plum PS. et al. Self-expanding metal stents versus endoscopic vacuum therapy in anastomotic leak treatment after oncologic gastroesophageal surgery. J Gastrointest Surg 2019; 23: 67-75